+
Site Tour

Review the Trends | Mitral focus

Revisit the most significant moments of the past year and learn more about the the latest emerging evidences in M-TEER and intermediate risk patients management.

LEARN MORE:

AV Valves Summit 2024

Related Videos

Trending Controversies | AV Valves

Navigating the Anatomy | Tricuspid focus

AV Valves Summit 2024 | Opening of Day 2

Review the Trends | Tricuspid focus

EACVI Summit 2023: Congress symposium

LAAO Summit 2023: Anatomy & imaging – The future

LAAO Summit 2023: Minimal anti-thrombotic therapy

Premiclose 2022: Complications in PDA closure

Landmark trials changing the Guidelines C. Skurk

M-TEER: echo procedural approach - 2025

LAAO Summit 2022: The future of imaging

TRENDING TOPICS

Discover MitraClip and TriClip G5 systems

MitraClip & TriClip G5: Control meets Efficiency

MitraClip™ patient story:
Julie

A patient with severe mitral regurgitation treated with Abbott’s minimally-invasive mitral valve repair technology

HFA Tutorials 2025
I. Stankovic

HFA Tutorials 2025
STRAIN and echo workshop | How to assess an HF patient

CONNEXT


HUB
RELATED RESOURCES

ESC 2021: HF & VHD Guidelines

ACC 2023: COAPT™ trial

PDA Patient Guide

EXPAND Study: Data overview

CONNEXT


LIVE
RELATED EVENTS

SAFETY IS A JOURNEY | J. Van der Heyden & C. Besler

AV Valves Summit 2024 | Closing of Day 1

PremiClose 2024: The PDA, when to intervene

LAAO Summit 2023: Minimal anti-thrombotic therapy

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline